WGS Q1 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q1 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$87M+39.6% YoY

Gross Profit

$58M67.1% margin

Operating Income

-$5M-5.2% margin

Net Income

-$7M-7.5% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-8.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$446M

Total Liabilities

$189M

Stockholders' Equity

$257M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$62M	+39.6%
Gross Profit	$58M	$37M	+56.3%
Operating Income	-$5M	-$14M	+66.7%
Net Income	-$7M	-$20M	+67.7%

Revenue Segments

Diagnostic Test

$86M50%

Diagnostic Test, Third Party Insurance

$68M39%

Diagnostic Test, Institutional Customers

$18M10%

Product and Service, Other

$1M1%

Diagnostic Test, Self Pay

$96,0000%